The DOI matches its Crossref record; 233 of the 234 references it cites were found in a registry or an index.
Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer’s disease
Abstract
Compelling evidence from basic molecular biology has demonstrated the dual roles of microglia in the pathogenesis of Alzheimer's disease (AD). On one hand, microglia are involved in AD pathogenesis by releasing inflammatory mediators such as inflammatory cytokines, complement components, chemokines, and free radicals that are all known to contribute to beta-amyloid (Aβ) production and accumulation. On the other hand, microglia are also known to play a beneficial role in generating anti-Aβ antibodies and stimulating clearance of amyloid plaques. Aβ itself, an inducer of microglia activation and neuroinflammation, has been considered as an underlying and unifying factor in the development of AD. A vicious cycle of inflammation has been formed between Aβ accumulation, activated microglia, and microglial inflammatory mediators, which enhance Aβ deposition and neuroinflammation. Thus, inhibiting the vicious cycle seems to be a promising treatment to restrain further development of AD. With increasing research efforts on microglia in AD, intervention of microglia activation and neuroinflammation in AD may provide a potential target for AD therapy in spite of the provisional failure of nonsteroidal antiinflammatory drugs in clinical trials.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ, especially the Aβ1-42 oligomer and fibril, is an established instigator of neuroinflammation (Cai et al., 2014).”
From LC3-Associated Endocytosis Facilitates β-Amyloid Clearance and Mitigates Neurodegeneration in Murine Alzheimer’s Disease (2019) · cites this paper as Cai et al., 2014
Citations
Cites
The pro- and anti-inflammatory properties of the cytokine interleukin-6
Scheller, J., Chalaris, A., Schmidt-Arras, D., & Rose-John, S. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.034 · Cited by 3,212
Microglial Dysfunction and Defective β-Amyloid Clearance Pathways in Aging Alzheimer's Disease Mice
Hickman, S. E., Allison, E. K., & El Khoury, J. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.0616-08.2008 · Cited by 1,329
Goedert, M., Spillantini, M. G., Cairns, N. J., & Crowther, R. A. (1992) · Neuron · doi:10.1016/0896-6273(92)90117-v · Cited by 1,122
Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095
Microglia and neuroinflammation: a pathological perspective
Streit (2004) · Journal of Neuroinflammation · doi:10.1186/1742-2094-1-14 · Cited by 1,039
Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 1,013
Neurovascular mechanisms and blood–brain barrier disorder in Alzheimer’s disease
Bell, R. D., & Zloković, B. V. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0522-3 · Cited by 883
Matrix metalloproteinases in neuroinflammation
Rosenberg, G. A. (2002) · Glia · doi:10.1002/glia.10108 · Cited by 868
Oxidative Stress and the Pathogenesis of Alzheimer's Disease
Zhao, Y., & Zhao, B. (2013) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2013/316523 · Cited by 855
Tilg, H., Trehu, E., Atkins, M., Dinarello, C., & Mier, J. (1994) · Blood · doi:10.1182/blood.v83.1.113.113 · Cited by 817
Flagged first, then by citations
1 of the 234 references couldn’t be matched to a known paper.
Research works printed but not linked: 24
- Dubinina EE, 2007, Adv Gerontol, 20, 109
- Weitz TM, 2012, Int J Alzheimer's Dis, 2012, 314185
- Imamoto K, 1981, Prog Clin Biol Res, 59, 125
- Wierzba-Bobrowicz T, 2002, Folia Neuropathol, 40, 125
- Krause DL, 2010, Int J Alzheimer's Dis, 2010, doi: 10.4061/20 · DOI
- Sochocka M, 2013, CNS Neurol Disord Drug Targets
- Lampron A, 2013, J Comp Neurol
- McLarnon JG, 2012, Am J Neurodegener Dis, 1, 199
- Thanopoulou K, 2010, Proc Natl Acad Sci USA, 107, 20816, 10.1073/pnas.1005888107 · DOI · Paper page
- Pflanzner T, 2010, Neurobiol Aging, 32, 2323
- Lee KW, 2009, J Neurochem, 108, 165
- 10.1002/glia.10108 · DOI
- Eckman EA, 2005, Biochem Soc Trans, 33, 1101, 10.1042/BST0331101 · DOI
- 10.1111/j.14714159.2010.06899.x · DOI
- Zou K, 2008, Rev Neurosci, 19, 203
- 10.1523/JNEUROSCI.0616-08.2008 · DOI · Paper page
- Chiarini A, 2006, Ital J Anat Embryol, 111, 221
- Samuelsson M, 2005, Int J Mol Med, 16, 449
- Yan SD, 1998, Restor Neurol Neurosci, 12, 167
- Gan L, 2004, J Biol Chem, 279, 5565, 10.1074/jbc.M306183200 · DOI
- Lee HS, 2007, Pharmazie, 62, 937
- Wilkinson K, 2012, Int J Alzheimer's Dis, 2012, 489456
- Nakamura K, 2006, J Neurosci Res, 84, 874, 10.1002/jnr.20992 · DOI
- Christie RH, 1996, Am J Pathol, 148, 399
Cited by
Sorted by citations
Items 101–200 of 587
Wang, M., Liu, T., Chen, S., Wu, M., Han, J., & Li, Z. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112874 · Cited by 65
Liu, Q. F., Xie, T., Xi, Y., Li, L., Mo, F., Liu, X., Liu, Z., Gao, J., & Yuan, T. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c04687 · Cited by 66
Giorgi, F. S., Galgani, A., Puglisi‐Allegra, S., Limanaqi, F., Busceti, C. L., & Fornai, F. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24718 · Cited by 69
Althobaiti, N. A. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115212 · Cited by 64
Exosomes: a novel therapeutic target for Alzheimer’s disease?
Cai, Z., Ke, Z.-Y., Xiao, M., & Quazi, S. H. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.232490 · Cited by 64
Insights into the Potential Role of Mercury in Alzheimer’s Disease
Bjørklund, G., Tinkov, A. A., Dadar, M., Rahman, M. M., Chirumbolo, S., Skalny, A. V., Геннадиевна, С. М., Haley, B. E., Ajsuvakova, O. P., & Aaseth, J. (2019) · Journal of Molecular Neuroscience · doi:10.1007/s12031-019-01274-3 · Cited by 64
Leko, M. B., Horvat, L. L., Španić, E., Zubčić, K., Hof, P. R., & Šimić, G. (2023) · Biomedicines · doi:10.3390/biomedicines11041161 · Cited by 64
Liu, H., Wang, J., Wang, J., Wang, P., & Xue, Y. (2015) · Brain Research · doi:10.1016/j.brainres.2015.05.035 · Cited by 63
Giuffrè, M., Moretti, R., Campisciano, G., da Silveira, A. B. M., Monda, V., Comar, M., Bella, S. D., Antonello, R. M., Luzzati, R., & Crocè, L. S. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9113705 · Cited by 64
Kim, Y., Lim, J., & Oh, J. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117277 · Cited by 67
Chiu, Y., Lin, C., Lee, M.-C., Hsieh‐Li, H. M., Chen, C., Wu, Y., Chang, K., & Lee‐Chen, G. (2021) · Aging · doi:10.18632/aging.203125 · Cited by 61
Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer’s Disease
Liu, Y., Cheng, X. M., Li, H., Hui, S., Zhang, Z., Yang, X. J., & Peng, W. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.908076 · Cited by 63
Mishra, P., Silva, A., Sharma, J., Nguyen, J., Pizzo, D. P., Hinz, D., Sahoo, D., & Cherqui, S. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112956 · Cited by 64
Sun, H., Wu, Z., Nie, X.-W., & Bian, J. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200905143550 · Cited by 62
Hambali, A., Kumar, J., Hashim, N. F. M., Maniam, S., Mehat, M. Z., Cheema, M. S., Mustapha, M., Adenan, M. I., Stanslas, J., & Hamid, H. A. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.712317 · Cited by 65
Lee, H., Jeon, S. G., Kim, J., Kang, R. J., Kim, S., Han, K., Park, H., Kim, K., Sung, Y. M., Nam, H. Y., et al. (2021) · Aging Cell · doi:10.1111/acel.13332 · Cited by 62
Matsushita, K., Yamada-Furukawa, M., Kurosawa, M., & Shikama, Y. (2020) · Journal of Inflammation Research · doi:10.2147/jir.s255309 · Cited by 64
Locus Coeruleus Modulates Neuroinflammation in Parkinsonism and Dementia
Giorgi, F. S., Biagioni, F., Galgani, A., Pavese, N., Lazzeri, G., & Fornai, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228630 · Cited by 63
Potential neuroprotection by Dendrobium nobile Lindl alkaloid in Alzheimer's disease models
Li, D., Zheng, C.-Q., Zhang, F., & Shi, J.-S. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.324824 · Cited by 60
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy
Rosa, F. L., Saresella, M., Marventano, I., Piancone, F., Ripamonti, E., Al‐Daghri, N. M., Bazzini, C., Zoia, C., Conti, E., Ferrarese, C., et al. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181259 · Cited by 61
Fan, K., Li, D., Zhang, Y., Han, C., Liang, J., Hou, C., Xiao, H., Ikenaka, K., & Ma, J. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0268-x · Cited by 58
Yang, R., Liu, S., Zhou, J., Bu, S.-H., & Zhang, J. (2017) · Immunopharmacology and immunotoxicology · doi:10.1080/08923973.2017.1344989 · Cited by 50
Abdi, M., Pasbakhsh, P., Shabani, M., Nekoonam, S., Sadeghi, A., Fathi, F., Abouzaripour, M., Mohamed, W. M. Y., Zibara, K., Kashani, I. R., et al. (2021) · Neurotoxicity Research · doi:10.1007/s12640-021-00417-y · Cited by 57
Wu, M., Zhai, Y., Liang, X., Chen, W., Lin, R., Ma, L., Huang, Y., Zhao, D., Liang, Y., Zhao, W., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.842814 · Cited by 59
Song, Z., Xie, X., Chen, Y., Zhang, B., Li, X., Yang, Y., Mo, W., Zhang, J., & Xu, D. (2025) · Immunity · doi:10.1016/j.immuni.2025.07.024 · Cited by 62
The Use of Antimicrobial and Antiviral Drugs in Alzheimer’s Disease
Iqbal, U., Zeng, E., & Pasinetti, G. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144920 · Cited by 55
Understanding the Modulatory Effects of Cannabidiol on Alzheimer’s Disease
Xiong, Y., & Lim, C. (2021) · Brain Sciences · doi:10.3390/brainsci11091211 · Cited by 60
RNA-Seq transcriptomic profiling of primary murine microglia treated with LPS or LPS + IFNγ
Pulido-Salgado, M., Vidal-Taboada, J. M., Barriga, G. G.-D., Solà, C., & Saura, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-34412-9 · Cited by 53
Potential neurotoxic activity of diverse molecules released by microglia
Lindhout, I. A., Murray, T. E., Richards, C. M., & Klegeris, A. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105117 · Cited by 58
Mohammadi, N., Asle‐Rousta, M., Rahnema, M., & Amini, R. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174506 · Cited by 55
Recent advances in understanding the mechanisms of PM2.5-mediated neurodegenerative diseases
Zhu, X., Ji, X., Shou, Y., Huang, Y., Hu, Y., & Wang, H. (2020) · Toxicology Letters · doi:10.1016/j.toxlet.2020.04.017 · Cited by 55
Li, Q., Cui, J., Chen, F., Liu, M., Min, G., & Li, L. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170177 · Cited by 53
Wang, Q., Lu, M., Zhu, X., Gu, X., Zhang, T., Xia, C., Yang, L., Xu, Y., & Zhou, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113412 · Cited by 52
The Effect of A 2A Receptor Antagonist on Microglial Activation in Experimental Glaucoma
Liu, X., Huang, P. C., Wang, J., Yang, Z., Huang, S., Luo, X., Qi, J., Shen, X. P., & Zhong, Y. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-18024 · Cited by 52
Tan, X., Liang, Z., Li, Y., Zhi, Y., Yi, L., Bai, S., Forest, K. H., Nichols, R. A., Dong, Y., & Li, Q. X. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.112968 · Cited by 52
Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer’s disease
Coles, M., Steiner-Lim, G. Z., & Karl, T. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.962922 · Cited by 57
Neurodegenerative Diseases: Their Onset, Epidemiology, Causes and Treatment
Zaib, S., Javed, H., Khan, I. A., Jaber, F. T., Sohail, A., Zaib, Z., Mehboob, T., Tabassam, N., & Ogaly, H. A. (2023) · ChemistrySelect · doi:10.1002/slct.202300225 · Cited by 53
Chen, Z., Wang, X., Du, S., Liu, Q., Xu, Z., Guo, Y., & Lin, X. (2024) · Chinese Medicine · doi:10.1186/s13020-024-00900-6 · Cited by 59
Ribeiro, V. T., de Souza, L. C., & Silva, A. C. S. E. (2019) · Protein and Peptide Letters · doi:10.2174/0929866527666191230103739 · Cited by 50
Ahmad, R., Khan, A., Lee, H. J., Rehman, I. U., Khan, I., Alam, S. I., & Kim, M. O. (2020) · Biomedicines · doi:10.3390/biomedicines8100380 · Cited by 50
The chemistry of gut microbiome in health and diseases
Lau, A., Tan, L. T., Mutalib, N. A., Wong, S. H., Letchumanan, V., & Lee, L. (2021) · Progress In Microbes & Molecular Biology · doi:10.36877/pmmb.a0000175 · Cited by 55
Environmental factors in the development and progression of late-onset Alzheimer’s disease
Wainaina, M. N., Chen, Z., & Zhong, C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1425-9 · Cited by 53
Influence of the Microbiota-Gut-Brain Axis on Cognition in Alzheimer’s Disease
Escobar, Y.-N. H., O’Piela, D., Wold, L. E., & Mackos, A. R. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-215290 · Cited by 52
Fan, M., Wang, C., Zhao, X., Jiang, Y. Z., & Wang, C. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110287 · Cited by 51
Xing, H., Guo, S., Zhang, Y., Zheng, Z., & Wang, H. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5369 · Cited by 49
Ullah, R., & Lee, E. J. (2023) · Experimental Neurobiology · doi:10.5607/en23014 · Cited by 51
Liu, Y., Zhang, Y., Liu, P., Bai, H., Li, X., Xiao, J., Yuan, Q., Geng, S., Yin, H., Zhang, H., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2018.11.004 · Cited by 45
RetractedImplications of the Human Gut–Brain and Gut–Cancer Axes for Future Nanomedicine
Javed, I., Cui, X., Wang, X., Mortimer, M., Andrikopoulos, N. K., Li, Y., Davis, T. P., Zhao, Y., Ke, P. C., & Chen, C. (2020) · ACS Nano · doi:10.1021/acsnano.0c07258 · Cited by 47
Zhang, J., Song, N., Liu, Y., & Guo, J. (2021) · Neurochemical Research · doi:10.1007/s11064-020-03198-6 · Cited by 48
Kong, D., Park, K. H., Kim, D., Kim, N. G., Lee, S., Shin, N., Kook, M. G., Kim, Y. B., & Kang, K. (2023) · Cell Death Discovery · doi:10.1038/s41420-022-01288-8 · Cited by 49
Fronza, M. G., Alves, D. A. C., Praticò, D., & Savegnago, L. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.102033 · Cited by 47
Roles of sigma-1 receptors in Alzheimer's disease.
Jin, J., Fang, M., Zhao, Y., & Liu, X. (2015) · PubMed · Cited by 47
Curcumin and neurological diseases
Adami, R., & Bottai, D. (2020) · Nutritional Neuroscience · doi:10.1080/1028415x.2020.1760531 · Cited by 49
Cell type-specific potential pathogenic genes and functional pathways in Alzheimer’s Disease
Wang, X., & Li, L. (2021) · BMC Neurology · doi:10.1186/s12883-021-02407-1 · Cited by 47
Ren, D., Fu, Y., Wang, L., Liu, J., Zhong, X., Yuan, J., Jiang, C., Wang, H., & Li, Z. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153627 · Cited by 45
Fu, Y., & Jia, J. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.638772 · Cited by 45
Dysfunction of the neurovascular unit in diabetes-related neurodegeneration
Yan, C., Zhou, Y., Chen, Q., Luo, Y., Zhang, J. H., Huang, H., & Shao, A. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110656 · Cited by 47
Role of Microglia in Herpesvirus-Related Neuroinflammation and Neurodegeneration
Patrycy, M., Chodkowski, M., & Krzyżowska, M. (2022) · Pathogens · doi:10.3390/pathogens11070809 · Cited by 47
IL-17A promotes the progression of Alzheimer’s disease in APP/PS1 mice
Cao, M., Liu, J., Zhang, X., Wang, Y., Hou, Y., Song, Q., Cui, Y., Zhao, Y., & Wang, P. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00397-x · Cited by 49
DiMeglio, M., Furey, W., Hajj, J., Lindekens, J., Patel, S. J., Acker, M. G., Bavaria, J. E., Szeto, W. Y., Atluri, P., Haber, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-42351-2 · Cited by 43
Mercury and Alzheimer’s disease: a look at the links and evidence
Azar, J., Yousef, M. H., El‐Fawal, H. A. N., & Abdelnaser, A. (2021) · Metabolic Brain Disease · doi:10.1007/s11011-020-00649-5 · Cited by 46
Neuroprotective Potency of Neolignans in Magnolia officinalis Cortex Against Brain Disorders
Zhu, S., Liu, F., Zhang, R., Xiong, Z., Zhang, Q., Hao, L., & Chen, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.857449 · Cited by 44
Lee, A. Y., Lee, M. H., Lee, S., & Cho, E. J. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00836 · Cited by 43
Wong, C. H., Gan, S. Y., Tan, S. C., Gany, S. A., Ying, T., Gray, A. I., Igoli, J. O., Chan, E. W. L., & Phang, S. M. (2018) · Journal of Applied Phycology · doi:10.1007/s10811-018-1495-1 · Cited by 42
Saito, T., Hisahara, S., Iwahara, N., Emoto, M. C., Yokokawa, K., Suzuki, H., Manabe, T., Matsumura, A., Suzuki, S., Matsushita, T., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.014 · Cited by 42
Qin, X., Shan, Q., Fang, H., Wang, Y., Chen, P., Xiong, Z., Swaab, D. F., & Zhou, J. (2021) · Acta Neuropathologica · doi:10.1007/s00401-021-02371-7 · Cited by 42
Porphyromonas gingivalis-Induced Neuroinflammation in Alzheimer’s Disease
Olsen, I. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.691016 · Cited by 41
Alzheimer’s Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
Alawode, D. O. T., Fox, N. C., Zetterberg, H., & Heslegrave, A. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.837390 · Cited by 41
Mitochondrial DNA and Inflammation in Alzheimer’s Disease
Galizzi, G., & Carlo, M. D. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45110540 · Cited by 43
Page, A. Y. L., Lamoureux, J., Bourgade, K., Frost, E. H., Pawelec, G., Witkowski, J. M., Larbi, A., Dupuis, G., & Fülöp, T. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170124 · Cited by 42
Scallop-derived plasmalogens attenuate the activation of PKCδ associated with the brain inflammation
Sejimo, S., Hossain, M. S., & Akashi, K. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.06.084 · Cited by 41
McCarty, M. F., & Assanga, S. B. I. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.06.032 · Cited by 42
Westfall, S., Iqbal, U. H., Sebastian-Valverde, M., & Pasinetti, G. M. (2019) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2019.06.013 · Cited by 42
Neuroinflammation in Alzheimer’s Disease: Microglia, Molecular Participants and Therapeutic Choices
Wang, H., Shen, Y., Chuang, H.-Y., Chiu, C., Ye, Y., & Zhao, L. (2019) · Current Alzheimer Research · doi:10.2174/1567205016666190503151648 · Cited by 43
Kirabali, T., Rust, R., Rigotti, S., Siccoli, A., Nitsch, R. M., & Kulic, L. (2020) · Brain Pathology · doi:10.1111/bpa.12895 · Cited by 43
Jiang, J., Chang, X., Nie, Y., Shen, Y., Liang, X., Peng, Y., & Chang, M. (2021) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00782 · Cited by 43
Fan, Z., Ren, T., Wang, Y., Jin, H., Shi, D., Tan, X., Ge, D., Hou, Z., Jin, X., & Yang, L. (2022) · Biomaterials · doi:10.1016/j.biomaterials.2022.121452 · Cited by 41
Recent Aspects of Periodontitis and Alzheimer’s Disease—A Narrative Review
Cichońska, D., Mazuś, M., & Kusiak, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052612 · Cited by 47
Yeo, E. T. Y., Wong, K. W. L., See, M. L., Wong, K. Y., Gan, S. Y., & Chan, E. W. L. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.02.025 · Cited by 40
Herman, F. J., Westfall, S., Brathwaite, J. S., & Pasinetti, G. M. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00867 · Cited by 43
The Interaction Between Neuroinflammation and β-Amyloid in Cognitive Decline in Parkinson’s Disease
Ghadery, C., Koshimori, Y., Christopher, L., Kim, J., Rusjan, P., Lang, A. E., Houle, S., & Strafella, A. P. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01714-6 · Cited by 42
Ge, Y.-T., Zhong, A.-Q., Xu, G., & Lu, Y. (2019) · Immunopharmacology and Immunotoxicology · doi:10.1080/08923973.2019.1666406 · Cited by 41
Furosemide as a Probe Molecule for the Treatment of Neuroinflammation in Alzheimer's Disease.
Wang, Z.-Y., Vilekar, P., Huang, J.-B., & Weaver, D. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00445 · Cited by 33
Unveiling the Complex Role of Exosomes in Alzheimer’s Disease
Sun, M., & Chen, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s466821 · Cited by 39
Ren, H., Yan, P., Wang, D., Hao, H., Han, R., Qi, C., Zhang, W., He, W., Shi, F., & Liu, Q. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106912 · Cited by 39
Liu, N., Liang, X., Chen, Y., & Xie, L. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102199 · Cited by 44
Raha, S., Lee, H. J., Yumnam, S., Hong, G. E., Saralamma, V. V. G., Ha, Y. L., Kim, J. O., Kim, Y. S., Heo, J., Lee, S. J., et al. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.07.017 · Cited by 39
Zhang, C., Hu, L., Liu, D., Huang, J., & Lin, W. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00760 · Cited by 41
Cerebral sterile inflammation in neurodegenerative diseases
Otani, K., & Shichita, T. (2020) · Inflammation and Regeneration · doi:10.1186/s41232-020-00137-4 · Cited by 39
Lee, H., Woo, H., Lee, H.-E., Jeon, H., Ryu, K., Nam, J. H., Jeon, S. G., Park, H., Lee, J.-S., Han, K., et al. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.08.030 · Cited by 39
Prospective Role of Polyphenolic Compounds in the Treatment of Neurodegenerative Diseases
Akter, R., Rahman, H., Behl, T., Chowdhury, M. A. R., Manirujjaman, M., Bulbul, I. J., Elshenawy, S. E., Ţiţ, D. M., & BUNGAU, S. G. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210218084444 · Cited by 40
Cai, Z., Zhou, Y., Liu, Z., Ke, Z., & Tian, F. (2015) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s84755 · Cited by 37
Beneficial effects of curtailing immune susceptibility in an Alzheimer’s disease model
Benedetto, G. D., Burgaletto, C., Carta, A. R., Saccone, S., Lempereur, L., Mulas, G., Loreto, C. D., Bernardini, R., & Cantarella, G. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1554-9 · Cited by 38
Han, K., Kang, R. J., Jeon, H., Lee, H., Lee, J.-S., Park, H., Jeon, S. G., Suk, K., Seo, J., & Hoe, H. (2020) · Cells · doi:10.3390/cells9071655 · Cited by 37
Deidda, G., & Biazzo, M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.753915 · Cited by 37
Exosomes Mediate APP Dysregulation via APP-miR-185-5p Axis
Ding, L., Yang, X., Xia, X., Li, Y., Wang, Y., Li, C., Sun, Y., Gao, G., Zhao, S., Sheng, S., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.793388 · Cited by 37
Zhang, Y., Zhao, Y., Zhang, J., Gao, Y., Li, S., Chang, C., Yu, D., & Yang, G. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.136206 · Cited by 36
Role of Microglial Cells in the Pathophysiology of MS: Synergistic or Antagonistic?
Mado, H., Adamczyk-Sowa, M. H., & Sowa, P. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24031861 · Cited by 43
Montalbano, M., Majmundar, L., Sengupta, U., Fung, L., & Kayed, R. (2022) · Brain Pathology · doi:10.1111/bpa.13112 · Cited by 35
The Ambiguous Role of Microglia in Aβ Toxicity: Chances for Therapeutic Intervention
Merlo, S., Spampinato, S. F., Caruso, G. I., & Sortino, M. A. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200131105418 · Cited by 35
Metadata
- Authors
- Cai, Z., Hussain, M. D., & Yan, L.-J.
- Affiliations
- Anhui Medical University (CN)
- Texas A&M Health Science Center (US)
- University of North Texas Health Science Center (US)
- Corresponding author
- Cai, Zhiyou
- Venue
- International Journal of Neuroscience
- Publisher
- Informa UK Limited
- Published
- 2013-09-12
- Volume
- 124
- Issue
- 5
- Pages
- 307-321
- ISSN
- 0020-7454 (ISSN-L)
- 1543-5245
- OpenAlex
- W2096407545
- Cited by
- 583
- References
- 234
- Citations by year
- 2026: 17 · 2025: 45 · 2024: 72 · 2023: 86 · 2022: 67 · 2021: 82 · 2020: 72 · 2019: 54 · 2018: 45 · 2017: 13 · 2016: 14 · 2015: 12 · 2014: 3 · 2013: 1
- FWCI
- 0.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- International Journal of Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- microglia, neuroinflammation, amyloid-beta, Alzheimer's disease, microglial activation, inflammatory cytokines, complement system, chemokines, free radicals, amyloid plaque clearance, anti-amyloid antibodies, anti-inflammatory therapy
- MeSH terms
- Alzheimer Disease, Humans, Inflammation, Amyloid beta-Peptides, Microglia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review